• In the media
  • Industrie moet meer doen voor beschikbaar hou...
Media - published on 23 Jan 2018

Industrie moet meer doen voor beschikbaar houden werkzame antibiotica

Rinke van den Brink of NOS reports on the Antimicrobial Resistance Benchmark and how companies should do more to ensure the effective antibiotics remain available to patients.

This article covers the actions pharmaceutical companies must take to ensure that effective antibiotics remain available to patients. It also states that companies must develop new antibiotics and better control where antibiotic resistance arises.


Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.